Showing 301 - 320 of 404 results
Dr Michelle Jones-Lennon leads the delivery of the Capital Portfolio for the Nuclear Science & Technology group across both Lucas Heights and Clayton campuses of ANSTO. She is also the Program Director for the BRIGHT Pr
Kathleen manages the quality and document management systems, and oversees procedures for inspection, testing, and calibration of equipment and systems, to support the accelerator operations and beam lines.
Researchers and industry partners from UNSW Australia, the Australian Centre for Nanomedicine, Children’s Cancer Institute and Inventia Life Sciences Pty Ltd have been awarded the 2021 ANSTO Eureka Prize for Innovative Use of Technology for their method to rapidly-produce 3D cell structures
With a well-established portfolio of nuclear research and the operation of Australia's only nuclear reactor OPAL, ANSTO scientists conduct both fundamental and applied research on fuel for current, advanced, and future nuclear technology systems.
The Titan Krios cryo-electron microscope reveals the inner workings of life at the cellular level.
Research highlights how biodistribution of a toxic substance essential to understand all exposure risks.
ANSTO researchers have taken up the challenge to develop a coating for the cladding used in nuclear reactors to prevent it from taking up hydrogen and releasing it if temperatures get too high and repair itself if damaged.
The unique magnetic properties and nontrivial quantum effects were observed and measured in an advanced material with potential application for quantum computing.
Commitment to undertake health research.
ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.
ANSTO provides multiple sources for radiation testing of materials and devices including Co-60 gamma sources, x-ray, proton and heavier ion-beams.
Guidance for obtaining and maintaining human or animal ethics approval at the Australian Synchrotron.
Role at ANSTO